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Introduction
Remote monitoring, or telemonitoring, can be regarded 
as a subdivision of telemedicine - the use of electronic 
and telecommunications technologies to provide and 
support health care when distance separates the 
participants [1]. Telemonitoring involves the use of audio, 
video, and other telecommunications and electronic 
information processing technologies to monitor patient 
status at a distance. Th e patient and the carer/system 
surveying, analysing or interpreting the data could be a 
few feet apart, but more often they will be in diﬀ erent 
areas of the same building, diﬀ erent buildings or diﬀ erent 
towns. In theory, they could even be in diﬀ erent countries 
or continents. Th e ﬁ rst case of direct transmission of a 
patient variable was that of an electrocardiograph (ECG) 
in 1905 by the inventor of the ECG, Einthoven [2]. 
However, the routine use of telemonitoring began in 1961 
when the ECG, respiratory rate, electro-oculogram and 
galvanic skin response of the ﬁ rst human in space, Yuri 
Gagarin, were continuously monitored by doctors on 
earth. Figure  1 shows typical ECG tracings from Neil 
Armstrong, Buzz Aldrin and Michael Collins, received at 
the Mission Control Center approximately 384,467 
kilometres away, during various periods of the Apollo 11 
mission to the moon in 1969.
Th is review will provide a broad overview of this 
resurgent ﬁ eld of medical remote monitoring and will 
describe the components of telemedicine, the current 
clinical utilisation and the ﬁ eld’s obvious challenges. 
Where possible, the article provides the appropriate 
references to allow the interested reader to obtain 
additional information.
Components of telemonitoring
At its simplest, the monitoring of a person’s vital signs 
involves an observer (usually a clinician) using their own 
senses directly (that is, without any intervening 
technology) to determine pulse rate, breathing rate, and 
so on. Added sophistication is produced by introducing 
simple technology such as a sphygmomanometer, stetho-
scope or thermometer, but still the act of monitoring is 
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monitoring, or telemonitoring, can be regarded as 
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and telecommunications technologies to provide 
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Most telemonitoring systems will incorporate fi ve 
components: data acquisition using an appropriate 
sensor; transmission of data from patient to clinician; 
integration of data with other data describing the 
state of the patient; synthesis of an appropriate action, 
or response or escalation in the care of the patient, 
and associated decision support; and storage of data. 
Telemonitoring is currently being used in community-
based healthcare, at the scene of medical emergencies, 
by ambulance services and in hospitals. Current 
challenges in telemonitoring include: the lack of a full 
range of appropriate sensors, the bulk weight and 
size of the whole system or its components, battery 
life, available bandwidth, network coverage, and 
the costs of data transmission via public networks. 
Telemonitoring also has the ability to produce a mass 
of data - but this requires interpretation to be of clinical 
use and much necessary research work remains to be 
done.
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performed directly by the clinician. All remaining 
processes, up to and including synthesising the appro-
priate response, occur in the clinician’s brain. Th e 
advance of technology, with the ﬁ nal stage of remote 
monitoring, has separated the various links in the chain 
between measuring and acting, and made explicit the 
chain of events, actions, processing and decisions linking 
the patient and the clinician.
Th e various links in this chain may include the 
following: data acquisition using an appropriate sensor; 
transmission of these data from patient to clinician; 
integration of the data with other data describing the 
state of the patient; synthesis of an appropriate action, or 
response or escalation in the care of the patient, and 
associated decision support; and data storage. Th e 
second, third and fourth items can occur in any order and 
may be repeated at diﬀ erent stages. Th ese stages will now 
be considered in detail.
Data acquisition using an appropriate sensor
Sensors, their modes of action, and the signals (vital 
signs) they measure are well known and are beyond the 
scope of this article. However, it is worth noting that 
newer modalities of measurement are emerging [3]. Any 
physiological parameter that can be measured can 
theoretically be telemonitored. Table  1 lists those 
variables for which this has been successfully achieved 
[4]. Measurements from sensors may be continuous or 
intermittent. Th e time to the next measurement may be 
determined by the last value. Th e sensor may be remote 
from the patient (for example, using Doppler radar to 
count breathing rate) [3] or intermittently used by the 
patient [5] or even continuously worn by the patient (for 
example, the remote patient monitoring system is inte-
grated within a ‘smart garment’) [6]. Th e measurement 
and collection of the data may be entirely automatic, or 
may involve a human (usually a clinician or the patient) 
in invoking the measurement or in performing it (for 
example, nurses entering vital signs data into a handheld 
computer) [7].
The transmission of data from patient to clinician
Depending on the setting, transmission of data can be by 
wired or wireless connections. Modalities include both 
wired and wireless computer networks, telephone net-
works and mobile phone networks. Systems that identify 
the available modalities and use them accordingly for the 
transmission of data are being developed. Th e trans-
mission technology is the essential glue in the various 
possible chain topologies. Its capabilities (bandwidth, 
coverage, cost of use, and so on) predicate the functions 
and capabilities of the other components. Transmission 
Figure 1. Electrocardiograph signal received at Mission Control during various periods of the Apollo 11 mission (NASA). (http://history.
nasa.gov/SP-368/p492b.htm)
Nangalia et al. Critical Care 2010, 14:233 
http://ccforum.com/content/14/5/233
Page 2 of 8
technologies will need to be chosen according to the 
particular use envisaged. Transmission of data from 
patient to clinician may be continuous or may only occur 
when a pre-deﬁ ned exception state has occurred (for 
example, when a potentially dangerous heart rhythm is 
detected) [8] or when connectivity is available.
Currently, diﬀ erent systems tend to use proprietary 
standards for transmission of data. As such systems 
become more common place, standards such as HL7 will 
become more widely used to allow integration and total 
systems building. Governments have set aside portions of 
the electromagnetic spectrum for the speciﬁ c use of 
wireless telemetry, though these are not always 
standardised across international regions and there are 
severe bandwidth limitations and interference issues. 
Th erefore, most medical device companies develop for 
the internationally agreed 2.4 to 2.5  GHz industrial, 
scientiﬁ c and medical band (ISM) [9], though, since this 
is not medicine-speciﬁ c, it is open to possible inter-
ference and overcrowding.
Wireless transmission protocols in use include wi-ﬁ 
(802.11 a/b/g/n) at 2.45 GHz and 5.8 GHz, and Bluetooth 
at approximately 2.45  GHz. Newer low-power, though 
lower-bandwidth, protocols that are also gaining favour 
include ANT [10] and Zigbee [11]. Th e Continua Health 
Alliance [12] has been formed to standardise both the 
protocols for transmission of medical data and the 
devices themselves, so devices can securely and reliably 
communicate with each other but this is at an early stage.
Integration of the data with other data describing the state 
of the patient
Th is may be done by a computer or a clinician, or both. 
Computer integration and/or analysis of data and their 
synthesis into information on which to act can happen 
anywhere in the chain and may be distributed across it. 
Amongst other things, this depends upon what data are 
being transmitted along the chain, which itself depends 
on the available bandwidth and its cost. Raw data could 
be transmitted (for example, three-lead ECG) or simply 
the heart rate; a full set of vital signs could be transmitted 
or simply a derived value such as an early warning score 
[13] or other index of patient severity of illness [14].
Th e detection of a particular patient state as a result of 
computer integration and/or analysis of data and their 
synthesis may be used to trigger transmission of the data 
themselves [8]. Th ese are all inter-related engineering 
decisions speciﬁ c to a particular application.
Synthesis of an appropriate action, or response or escalation 
in the care of the patient, and associated decision support
Th is depends on context. In hospital, it might be a 
decision to admit to an ICU or to call a rapid response 
team; in the community, the action could be to arrange a 
visit by a community nurse. Such a decision could be 
made by an ‘intelligent’ system but at present would 
certainly involve human input. Importantly, though, such 
‘systems’ could push the data to the responsible clinician 
for a decision to be made when pre-determined criteria 
had been satisﬁ ed, removing the need for continuous 
human monitoring. What such escalation (or de-
escalation) criteria should be is both context-dependent 
and probably unknown. Th e extent of synthesis and 
decision support ranges from applying the above criteria 
for escalating clinical input to simply making background 
contextual information available to the responsible 
clinician to reduce diagnostic and decision errors, and 
improve patient safety and quality of care [15].
Data storage
At one extreme this may be local storage of data in the 
sensing device to allow, for example, a breathing rate to 
be determined prior to transmission or the short-term 
storage of data to allow the data prior to a critical event 
to be transmitted as supporting information along with 
notiﬁ cation of the critical event [8]. At the other extreme, 
it could be the formation of a large database of vital signs 
to determine and validate calling criteria for rapid 
response team activation [7]. Such data are almost certain 
Table 1. Physiological parameters that have been 
successfully telemonitored [5]
Heart rate
Blood pressure 
Respiratory rate 
Temperature
Pulse oximetry
Heart sounds
Electrocardiograph (ECG)
Pacemaker parameters
Electroencephalogram (EEG)
Electromyograph (EMG)
Spirometry
Body weight physical activity
Fetal heart rate
Basal metabolic rate
O2 consumption 
CO2 production
Blood glucose
Blood lactate
Blood ethanol
Intracranial pressure
Intravesical pressure
Intrauterine pressure
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to become an essential part of the electronic patient 
record. Medico-legal as well as contractual and billing 
issues will demand the storage of the majority of these 
data.
Clinical use of telemonitoring
Telemonitoring is being used in the home, at the scene of 
a medical emergency, in transit via the ambulance service 
and in the hospital.
Home
In the home, telemonitoring is characterised by a patient 
being monitored by a number of devices and the 
subsequent, real time or delayed transmission of derived 
data via the domestic or mobile telephone service to a 
remote monitoring service or healthcare provider. Th ese 
devices may monitor physiological data (for example, 
pulse, blood pressure, SpO2, blood glucose) or the per for-
mance of equipment such as implantable deﬁ brillators or 
pacemakers [16,17]. Most commonly, telemonitoring is 
used for the distant surveil lance of patients with chronic 
disease, such as chronic heart failure, chronic obstructive 
pulmonary disease and diabetes mellitus. However, fetal 
heart rates and the level of activity of elderly people have 
also been monitored [4,18]. Th e same type of technology 
may also be used to record a patient’s subjective response 
to speciﬁ c pre-set questions about their health [5]. 
Table 2 lists a selection of studies with positive outcomes 
attributed to telemonitoring. It has been estimated that 
the use of remote monitoring of chronic disease to 
prevent deterioration by early detection and intervention 
in the community could save approximately $197 billion 
in the USA over the next 25 years [19].
However, other studies have not shown any change in 
measured parameters with home-based monitoring and 
intervention for asthma [20] or hypertension [21]. 
Systematic reviews on chronic disease management and 
telemonitoring, although acknowledging the potential 
beneﬁ t of telemonitoring, highlight the need for further 
research [22-24]. Interpretation of the signiﬁ cance of the 
reported results of most pre-hospital telemonitoring 
studies is diﬃ  cult because not only has the frequency of 
vital sign measurement been arbitrarily chosen - ranging 
from continuous to symptom-based [21,25-36] - but 
medical review and intervention based on the collected 
data also varied from immediately based on alarms to 
monthly [21,27-30,34,36-38].
Disaster medicine
Systems are being developed that would enable emer-
gency medical services to tag and physiologically monitor 
large numbers of patients at a remote site, that is, the site 
of the disaster or a triage centre [39]. Such systems would 
provide ﬁ rst responders, disaster command centres and 
supporting hospitals with medical data to track and 
monitor the condition of up to thousands of victims on a 
moment-to-moment basis using vital signs monitoring 
and location tagging (similar to global positioning system 
tagging).
Ambulance services
Use of telemedicine in ambulances has so far focussed 
primarily on patients suspected of suﬀ ering a myocardial 
infarction. ECG data from these patients has been 
transmitted to a designated hospital and a decision is 
then for either pre-hospital thrombolysis [40] or redirect-
ing the ambulance to a centre for primary angioplasty 
[41], both of which have been shown to reduce the time 
to treatment compared to traditional in-hospital assess-
ment. Other parameters transmitted from ambulances 
include non-invasive blood pressure, arterial oxygen 
satura tion, blood glucose concentration and body 
temperature [42].
In hospital
In hospital, the interest in telemonitoring has been driven 
by the need to balance the conﬂ icting requirements 
posed by increased population age, increased patient 
severity of illness, increased incidence of concurrent 
illness, reduced staﬃ  ng levels and raised patient expec-
tation regarding patient safety. Telemonitoring could be 
used in any area of a hospital, but is perhaps most 
pertinent in critical care areas and the general wards.
Critical care areas
In the USA, VISICU, a Philips healthcare company, has 
implemented over 30 remote ICU programmes, in which 
intensivists and physicians provide supplemental moni-
tor ing and management of ICU patients at workstations 
in an oﬀ -site, centralized facility (the eICU). Bedside 
monitor data, lab results, patient treatment charts, 
ventilator and other equipment settings and outputs 
from audiovisual equipment in the ICU patient rooms 
are available to the eICU staﬀ , who also have access to 
physician note- and order-writing applications. When 
the eICU team is allowed full and direct management of 
the patient, these systems have been reported to reduce 
mortality by up to 33% [43], number of ventilator days by 
up to 25% [43] and length of stay in the ICU by up to 17% 
[44]. A criticism of the eICU is that these beneﬁ ts may 
only be apparent in an environment where there is a 
shortage in the number of intensivists to adequately 
provide an onsite 24/7 specialist-led service. Other 
descriptions of the use of telemonitoring in critical care 
include the provision of support for patients requiring 
mechanical venti lation at home [45], which has proved to 
be success ful in the weaning of a patient from home 
mechanical ventilation without onsite specialist help [46]. 
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Systems that monitor patients’ physiological parameters 
during home hemodialysis also exist [47].
Remote monitoring of vital signs of ward patients 
provides the possibility of obtaining pre-ICU data - even 
to the point of using these data to decide if ICU 
admission is required. It may also allow earlier, safe dis-
charge of patients from the ICU as they can be reliably 
remotely monitored by ICU staﬀ . Perhaps, most interest-
ingly, it potentially allows ICU staﬀ  to survey the whole 
population of monitored in-patients and to intervene as 
necessary - a technology-enabled pro-active outreach 
service [7].
Ward patients
Many hospitalised patients suﬀ ering adverse events (for 
example, in-hospital cardiac arrest, unanticipated ICU 
admission or death) exhibit physiological deterioration in 
the period before the event [48-50]. Sometimes this is 
detected, but often there is insuﬃ  cient monitoring 
[51-55]. For example, the 2007 National Conﬁ dential 
Enquiry into Patient Outcome and Death report [54] 
noted that ‘not only are appropriate observations 
performed less often than is desirable, when they are 
performed, their frequency is inappropriately low in a 
signiﬁ cant proportion of patients’. Other failures in the 
Table 2. Telemonitoring studies with a positive outcome
Paper Setting Disease
Parameters 
measured 
(frequency)
Transmission 
frequency
Review 
frequency Outcome
Breslow 
2007 
[43,44]
In hospital - 
ICU
Multiple - all 
critically ill 
patients
Multiple 
continuously; 
all measured 
parameters + 
video monitoring
Continuously Continuously Reduced mortality by up to 33%, number of ventilator 
days by up to 25%, length of stay by up to 17%
Antonicelli 
et al. 2008 
[30]
Community Chronic heart 
failure (CHF)
BP (daily), ECG 
(weekly), body 
weight (weekly), 
24-h urine output 
(weekly)
Daily Weekly Telecare versus usual care: decreased hospital 
readmission 9 versus 26 (P < 0.01); trend towards 
decreased mortality 3 versus 5; total patients 28 versus 
29 (N = 57)
Fursse et al. 
2008 [29]
Community Diabetes, 
hypertension, 
CHF
Blood glucose 
(daily), BP (daily), 
SpO2 (daily)
Daily On alerts, 
regularly - 
not specifi ed
Mean reductions of 11 mmHg systolic and 2 mmHg 
diastolic in patients with CHF, 0.4% HbA1c in those with 
diabetes, and 12 mmHg systolic and 2 mmHg diastolic 
in those with hypertension (no control group; N = 29)
Green et al. 
2008 [31]
Community Hypertension BP (twice weekly) Twice weekly Fortnightly Higher proportion of patients (after 12 months) whose 
BP was controlled (<140/90); telemonitored group 56% 
versus usual care 31% (80% increase; N = 778)
Kisner et al. 
2008 [61]
In hospital - 
ward
Atrial fi brillation 
post CABG
SpO2 
(continuously)
Continuously On alerts Incidence of atrial fi brillation in telemonitored group 
was 14% versus 26% (prior to telemonitoring; P = 0.016; 
N = 119; control cohort = 238)
Morguet 
et al. 2008 
[33]
Community CHF Weight (daily), BP 
(daily), pulse rate 
(daily), ECG (on 
request)
Daily Twice weekly, 
on alerts
50% reduction in hospital admissions (38 versus 77/100 
patient years, P = 0.034), 54% reduction in hospital 
length of stay (317 versus 693 days/100 patient years; 
P < 0.0001) (N = 128)
Nakamoto 
et al. 2008 
[63]
Community Hypertension: 
drug trial of 
temlisartan versus 
amlodipine
BP (twice daily) Twice daily End of study Evening systolic BP reductions higher in telmisartan 
versus amlodipine group (13 ± 3 versus 6 ± 3 mmHg); 
non-signifi cant diff erences in morning BP reduction 
between both groups; better daytime normalisation 
with telmisartan (N = 40)
Nielsen et 
al. 2008 
[27]
Community ICD, pacemaker ECG (continuously) Daily, on alerts On alerts 26% of unplanned clinic visits initiated by 
telemonitored data (N = 260)
Ricci et al. 
2008 [28]
Community ICD, pacemaker ECG (continuously) Daily, on alerts Fortnightly, 
on alerts 
37% of patients had changes to their medication, 
device reprogramming, or were called in for further 
investigations (N = 117)
Woodend 
et al. 2008 
[34]
Community Angina, heart 
failure
BP (daily), weight 
(daily), ECG (not 
specifi ed)
Daily Weekly 32% reduction in hospital admission (0.4 versus 0.59 
hospital readmission rate per patient, P = 0.048); 46% 
reduction in length of stay in hospital if readmitted 
(2.11 versus 3.93 days, P = 0.038) (N = 249)
Parati et al. 
2009 [35]
Community Hypertension BP (not specifi ed) Not specifi ed On alerts Increased daytime BP normalization (<130/90), 62% 
versus 50% (P < 0.05); less frequent treatment changes, 
9% versus 14% (P < 0.05) (N = 228)
BP, blood pressure; CABG, coronary artery bypass graft; CHF, chronic heart failure; ECG, electrocardiograph; ICD, implantable cardioverter-defi brillator.
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system of recognising and responding to patient 
deterioration include a failure to call for experienced help 
and a failure of responders to respond [48-51].
Outreach/medical emergency team data appear to 
indicate that early identiﬁ cation and intervention of 
deteriorating patients reduces the incidence of adverse 
events. In one multicentre study Chen and colleagues 
[56] analyzed 11,242 serious adverse events and 3,700 
emergency team calls and found for every 10% of increase 
in the proportion of early emergency team calls there was 
a 2.0 reduction per 10,000 admissions in unexpected 
cardiac arrests (95% conﬁ dence interval (CI) 2.6 to 1.4), a 
2.2 reduction in overall cardiac arrests (95% CI 2.9 to 
1.6), and a 0.94 reduction in unexpected deaths (95% CI 
1.4 to 0.5).
It is now advised that a clear physiological monitoring 
plan, which details the parameters to be monitored and 
the frequency of observations, should be made for each 
patient, and that there should be a graded response to 
patient severity of illness [7,53]. Other recent reports also 
recommend an increase in the range and frequency of 
physiological parameters monitored in general ward 
patients [51-55]. Th is could be achieved by increasing 
levels of nurse staﬃ  ng, as this has been shown to reduce 
adverse outcomes [57], but there are limits to the extent 
to which nursing numbers can be increased. However, 
technology can enable the continuous capture and 
transmission of physiological parameters and the advent 
of early warning systems allows for a mechanism of 
automatic analysis of these signals, theoretically enabling 
the clinical expertise of medical professionals to be 
focussed on those patients who are at greatest risk of 
deterioration. Telemonitoring technology therefore has 
the potential to increase patient care and is thus regarded 
as an integral part of the UK National Health Service 
Connecting for Health Programme [58].
Th ere are many publications from ICUs, high 
dependency units or cardiac care units that describe data 
telemetry from a bed-bound patient to the nurses’ 
station. However, descriptions of the use of such tech-
nology in the general wards of hospitals are rare. Cale 
[59] has described the hospital-wide implementation of a 
wireless telemonitoring system in a Californian hospital 
that transmits patient parameters to a ‘war room’, where 
these are monitored by biomedical technicians 24 hours 
a day. Th e use of a wireless pulse oximeter in a Zurich 
hospital [60,61] is claimed to reduce the incidence of 
atrial ﬁ brillation (14% versus 26% prior to telemonitoring, 
P  =  0.016) in coronary artery bypass graft patients by 
early detection of desaturation and implementation of 
oxygen therapy. A unique characteristic of this system is 
that it either pages the doctor directly or sends an SMS 
text message to their mobile phone alerting them of the 
desaturation and providing a history of the event. In the 
UK, nurses in some hospitals use the VitalPAC system for 
collecting routine vital signs data at the bedside using 
standard personal digital assistants (PDAs) wirelessly 
linked to the hospital’s intranet system. Here raw and 
derived data are integrated with patient demographic and 
laboratory information, allowing raw physiology data, 
early warning scores, vital signs charts and oxygen 
therapy records to be made instantaneously available to 
any member of the hospital healthcare team [7].
Some obvious challenges
Currently, the technology for telemonitoring is far from 
mature and there are still technological issues to be 
addressed. Th ese include: the lack of a full range of 
appropriate sensors; the bulk weight and size of the 
whole system or its components (particularly in relation 
to patient-worn systems); the identiﬁ cation of invalid 
data (for example, from sensors that become detached/
displaced); battery life; available bandwidth; network 
coverage; and the costs of data transmission via public 
networks.
Th ere will also be challenges for adoption of such 
systems because individuals may see constant 
physiological surveillance as intrusive. As with genetics 
testing, there may even be insurance-related issues [62]. 
Th ere are also potential cultural problems to be tackled 
in relation to the deployment of such technology in 
health care organisations, as they produce requirements 
for new ways of working. Another major problem is that 
telemonitoring has the ability to produce a mass of data 
that require interpretation to be of use. New data analysis 
methods therefore need to be devised and validated. 
Mistakes in this analysis could have medico-legal 
conse quences.
However, despite all the potential hurdles, it is likely to 
be only a matter of time before smart systems continu-
ously monitor every patient from the moment they are 
admitted to the point of discharge from hospital (and 
possibly beyond).
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